SCHEMBL21814906

SCHEMBL21814906

COc1ccc(C(=O)N(O)C(C)(C)C)c(O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
HPGD P15428 3/20 0.58
CYP3A4 P08684 3/20 0.58
ALDH1A1 P00352 3/20 0.58
MAPK1 P28482 3/20 0.58
TSHR P16473 5/20 0.55
PDK2 Q15119 2/20 0.54
HSP90AA1 P07900 1/20 0.54
PDK1 Q15118 1/20 0.54
PDK3 Q15120 1/20 0.54
PDK4 Q16654 1/20 0.54
LMNA P02545 4/20 0.53
CYP2C19 P33261 3/20 0.53
CYP1A2 P05177 2/20 0.53
PGR P06401 2/20 0.53
SLC6A2 P23975 2/20 0.53
ADORA3 P0DMS8 1/20 0.53
AR P10275 1/20 0.53
CHRM1 P11229 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13543158 0.77 NPC1 (0.68) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL11321848 0.76 NPC1 (0.62) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL29365072 0.76 NPC1 (1.00) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL1514997 0.76 NPC1 (1.00) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL38652 0.76 NPC1 (1.00) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL11789746 0.75 TSHR (0.62) NPC1RAB9AHPGDCYP3A4ALDH1A1
Paeonol SCHEMBL3710243 0.74 HPGD (1.00) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL6851855 0.74 NPC1 (0.75) NPC1RAB9AHPGDCYP3A4ALDH1A1
Paeonol SCHEMBL29349833 0.74 HPGD (1.00) NPC1RAB9AHPGDCYP3A4ALDH1A1
SCHEMBL29380756 0.74 NPC1 (0.96) NPC1RAB9AHPGDCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12162871-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2024-12-10 US disclosed
US-11787791-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2023-10-17 US disclosed
US-11787791-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2023-10-17 US disclosed
US-11787791-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2023-10-17 US disclosed
US-20230295140-A1 INHIBITORS OF VAP-1 ACUCELA INC. 2023-09-21 US disclosed
US-20230295140-A1 INHIBITORS OF VAP-1 ACUCELA INC. 2023-09-21 US disclosed
US-20230295140-A1 INHIBITORS OF VAP-1 ACUCELA INC. 2023-09-21 US disclosed
US-20210387975-A1 INHIBITORS OF VAP-1 ACUCELA INC. 2021-12-16 US disclosed
US-20210387975-A1 INHIBITORS OF VAP-1 ACUCELA INC. 2021-12-16 US disclosed
EP-3856176-A2 INHIBITORS OF VAP-1 Acucela Inc. (US) 2021-08-04 EP disclosed
WO-2020069330-A2 INHIBITORS OF VAP-1 ACUCELA INC. (US) 2020-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787791-B2 Inhibitors of VAP-1 VAPB, VAPA, TOE1 NPC1 198/4885RAB9A 829/4885HPGD 4011/4885
US-20230295140-A1 INHIBITORS OF VAP-1 VAPB, VAPA, TOE1 NPC1 198/4885RAB9A 829/4885HPGD 4011/4885
US-20210387975-A1 INHIBITORS OF VAP-1 VAPB, VAPA, TOE1 NPC1 198/4885RAB9A 829/4885HPGD 4011/4885
US-12162871-B2 Inhibitors of VAP-1 VAPB, VAPA, TOE1 NPC1 198/4885RAB9A 829/4885HPGD 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.